FDA Study Data Technical Conformance Guide version 4.2 – Nov. 27, 2018

(46:23)

Some cancer drugs remain unproven 5 years after FDA's accelerated approval, study finds

(7:44)

FDA’s Clinical Regulatory Perspective: Designing First-In-Human Trial for Cellular and Gene Therapy

(36:56)

Lecture 3 - FDA Drug Approval 101- Reading and Interpreting Cancer Trials Series

(47:8)

FDA Study Data Technical Rejection Criteria (TRC): What you need to know!

(1:26:22)

Harvard-MIT Center for Reg. Science Lecture (4-4-23) - Dubious FDA drug Approvals

(57:39)

FDA Study Data Technical Conformance Guide v4.4 - Nov 22, 2019

(1:9:42)

What you should know about FDA Project Optimus for your oncology drug approval

(42:27)

FDA Clinical Investigator Training Course (CITC) 2024 – Day One – Session One

(2:14:51)

Demystifying FDA's Human Factors Guidance

(1:10:44)

The Food and Drug Administration Explained

(17:31)

New study of human brains shows there are enough microplastics to make a spoon

(5:22)

Should You Supplement With Berberine? - Rhonda Patrick

(15:36)

Basic SDTM concepts 1

(24:4)

Innovating medicine with AI: Here's what to know

(6:49)

WATCH: Sen. Bernie Sanders questions RFK Jr. in confirmation hearing

(8:21)

Assessment of Extractables/Leachables Data in ANDA Submissions

(31:55)

Chemistry and Manufacturing Requirements for Early Clinical Development: What’s in there? Prove it.

(1:2:19)

STUDY W/ ME (my entire study process + tips) 💻☆

(13:23)

Safety Reporting Requirements and Safety Assessment for IND and BA/BE Studies

(35:38)

FDA Draft Guidance on Statistical Approaches to Establishing Bioequivalence

(2:1:2)

An In-Depth Look at the Final FDA Guidance: Bioavailability Studies Submitted in NDAs or INDs

(2:35:24)

Recent FDA Feedback Regarding Extractable and Leachable Testing

(47:26)

10 More Facts about What FDA Does and Does Not Approve | #FDAFacts 11-20

(5:27)

Introduction (1/9) FDA MyStudies Mobile App System – May 9, 2019

(15:38)

FDA Clinical Investigator Training Course (CITC) 2024 (Day 1 of 3)

(4:38:30)

June 17, 2021- Introduction to FDA: History, Regulations, and Clinical Trial Design

(54:27)

How FDA Investigates Foodborne Illness Outbreaks

(12:8)

Webinar — Comparing CTA Submission (EMA/Health Canada) to IND Applications (FDA) for Phase I Trials

(51:57)

Walkthrough of an FDA Clinical Investigator Site Inspection (12/14) REdI 2017

(39:9)